Cellectar Biosciences Stock Price on February 23, 2024
| CLRB Stock | USD 1.46 0.06 3.95% |
Below is the normalized historical share price chart for Cellectar Biosciences extending back to June 14, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cellectar Biosciences stands at 1.46, as last reported on the 4th of December, with the highest price reaching 1.53 and the lowest price hitting 1.43 during the day.
If you're considering investing in Cellectar Stock, it is important to understand the factors that can impact its price. Cellectar Biosciences secures Sharpe Ratio (or Efficiency) of -0.2, which signifies that the company had a -0.2% return per unit of risk over the last 3 months. Cellectar Biosciences exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cellectar Biosciences' Risk Adjusted Performance of (0.16), standard deviation of 2.62, and Mean Deviation of 1.94 to double-check the risk estimate we provide.
At present, Cellectar Biosciences' Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 12.8 M, whereas Total Stockholder Equity is projected to grow to (1.3 M). . The current year's Price Earnings To Growth Ratio is expected to grow to 0.07, whereas Price To Sales Ratio is projected to grow to (1 K). Cellectar Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of November 2005 | 200 Day MA 2.6857 | 50 Day MA 1.97 | Beta 1.007 |
Cellectar |
Sharpe Ratio = -0.2008
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CLRB |
Estimated Market Risk
| 2.65 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.53 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cellectar Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cellectar Biosciences by adding Cellectar Biosciences to a well-diversified portfolio.
Price Book 40.4868 | Book Value (0.96) | Enterprise Value 42.6 M | Enterprise Value Ebitda (3.25) | Shares Float 29.6 M |
Related Headline
Aileron Therapeutics Headline on 23rd of February 2024
Acquisition by Armen Shanafelt of 20000 shares of Aileron Th... by Armen Shanafelt
Filed transaction by Aileron Therapeutics Inc director. Grant, award or other acquisition pursuant to Rule 16b-3
Cellectar Biosciences Valuation on February 23, 2024
It is possible to determine the worth of Cellectar Biosciences on a given historical date. On February 23, 2024 Cellectar was worth 3.35 at the beginning of the trading date compared to the closed value of 3.34. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cellectar Biosciences stock. Still, in general, we apply an absolute valuation method to find Cellectar Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cellectar Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cellectar Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 3.37 | 3.49 | 3.34 | 3.35 | 555,422 | |
02/23/2024 | 3.35 | 3.37 | 3.24 | 3.34 | 878,822 |
| 3.35 | 3.51 | 3.35 | 3.49 | 1,169,389 |
| Backtest Cellectar Biosciences | | | Cellectar Biosciences History | | | Cellectar Biosciences Valuation | Previous | Next |
Cellectar Biosciences Trading Date Momentum on February 23, 2024
| On February 26 2024 Cellectar Biosciences was traded for 3.49 at the closing time. The top price for the day was 3.51 and the lowest listed price was 3.35 . The trading volume for the day was 1.2 M. The trading history from February 26, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 4.49% . The overall trading delta against the current closing price is 31.74% . |
Cellectar Biosciences Fundamentals Correlations and Trends
By evaluating Cellectar Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cellectar Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cellectar financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cellectar Biosciences Stock history
Cellectar Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cellectar is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cellectar Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cellectar Biosciences stock prices may prove useful in developing a viable investing in Cellectar Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 12.2 M | 12.8 M | |
| Net Loss | -25.7 M | -24.5 M |
Cellectar Biosciences Stock Technical Analysis
Cellectar Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cellectar Biosciences Period Price Range
Low | December 4, 2024
| High |
0.00 | 0.00 |
Cellectar Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cellectar Biosciences December 4, 2024 Market Strength
Market strength indicators help investors to evaluate how Cellectar Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cellectar Biosciences shares will generate the highest return on investment. By undertsting and applying Cellectar Biosciences stock market strength indicators, traders can identify Cellectar Biosciences entry and exit signals to maximize returns
Cellectar Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cellectar Biosciences' price direction in advance. Along with the technical and fundamental analysis of Cellectar Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cellectar to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.16) | |||
| Jensen Alpha | (0.71) | |||
| Total Risk Alpha | (0.95) | |||
| Treynor Ratio | (0.51) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Cellectar Stock analysis
When running Cellectar Biosciences' price analysis, check to measure Cellectar Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectar Biosciences is operating at the current time. Most of Cellectar Biosciences' value examination focuses on studying past and present price action to predict the probability of Cellectar Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectar Biosciences' price. Additionally, you may evaluate how the addition of Cellectar Biosciences to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |